Safety and Immunogenicity of a Recombinant Protein RBD Fusion Heterodimer Vaccine Against SARS-CoV-2: Preliminary Results of a Phase 1-2A Dose-Escalating, Randomized, Double-Blind Clinical Trial Lorna Leal , Judit Pich , Laura Ferrer , Jocelyn Nava , Ruth Martí-Lluch , Ignasi Esteban , Edwards Pradenas , Dàlia Raïch-Regué , Antoni Prenafeta , Karla Escobar , Carmen Pastor , Marc Ribas-Aulinas , Benjamin Trinitè , Jordana Muñoz-Basagoiti , Gemma Domenech , Bonaventura Clotet , Júlia Corominas , Aida Corpes-Comes , Carme Garriga , Antonio Barreiro , Nuria Izquierdo-Useros , Joan Albert Arnaiz , Alex Soriano , José Ríos , Marga Nadal , Montserrat Plana , Julià Blanco , Teresa Prat , Elia Torroella , Rafel Ramos , the HIPRA-HH-1 study group crossref（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
